Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

thehindubusinessline.com - 'Not an adjunct to the pharma industry': Medical device representatives seek separate regulatory authority
'Not an adjunct to the pharma industry': Medical device representatives seek separate regulatory authority
BusinessLine

Close to a dozen medical device and civil society organisations, among others, have sought a National Medical Devices Regulatory Authority, with the autonomy of telecom body TRAI or insurance's IRDAI, and regulatory oversight of food authority…

swissinfo.ch - Jessica Davis Plüss (text) Kai Reusser (visuals) - Basel's world-beating pharma hub fights for place in new global order
Basel's world-beating pharma hub fights for place in new global order
www.swissinfo.ch

Few cities in the world have an identity so tightly bound to an industry as Basel and pharmaceuticals. Roche and Novartis, two of the world's biggest drugmakers, loom large over the city. Walk across any bridge in the city, and you can see the…

swissinfo.ch - swissinfo.ch - Swiss pharma companies flock to North Carolina
Swiss pharma companies flock to North Carolina
www.swissinfo.ch

Mountains, waterfalls, Atlantic beaches – North Carolina's natural beauty is captivating. But that's not why Swiss companies are moving to the state. It is rather thanks to an active investment promotion policy. This policy has become all…

chron.com - BridgeBio Pharma: Q2 Earnings Snapshot
BridgeBio Pharma: Q2 Earnings Snapshot
Chron

PALO ALTO, Calif. (AP) — PALO ALTO, Calif. (AP) — BridgeBio Pharma Inc. (BBIO) on Monday reported a loss of $152.2 million in its second quarter. On a per-share basis, the Palo Alto, California-based company said it had a loss of 78…

seekingalpha.com - SA Transcripts - BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call Transcript
BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call Transcript
Seeking Alpha

BridgeBio Pharma, Inc. (BBIO) Q2 2026 Earnings Call August 10, 2026 4:30 PM EDT Chinmay Shukla - Senior Vice President of Strategic Finance Neil Kumar - Co-Founder, CEO & Director Matthew Outten - Chief Commercial Officer Thomas Trimarchi - CFO &…

indianexpress.com - Express News Service - Gujarat pharma firm partners held for illegal sale of codeine cough syrup
Gujarat pharma firm partners held for illegal sale of codeine cough syrup
The Indian Express

4 min read Ahmedabad Make us preferred source on Google The Special Operations Group (SOG) of the Ahmedabad City Police has arrested two partners of Ahmedabad-based wholesale pharmaceuticals company on the charge of selling Codeine-based cough…

indianexpress.com - Anonna Dutt - 'Suggestions not accepted': Bill to overhaul drugs law faces opposition from pharma, medical device sector
'Suggestions not accepted': Bill to overhaul drugs law faces opposition from pharma, medical device sector
The Indian Express

5 min read New Delhi Make us preferred source on Google A Bill to overhaul the Drugs and Cosmetics Act, 1940, currently being circulated to stakeholder ministries, is facing fierce opposition from the country's nascent medical device sector.

marketbeat.com - BridgeBio Pharma Q2 Earnings Call Highlights
BridgeBio Pharma Q2 Earnings Call Highlights
MarketBeat

The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions BridgeBio Pharma NASDAQ: BBIO reported continued growth for its ATTR cardiomyopathy treatment Attruby in the second quarter of 2026, while advancing three late-stage…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Announces Earnings Results
BridgeBio Pharma (NASDAQ:BBIO) Announces Earnings Results
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.78) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.58) by ($0.20), FiscalAI…

marketbeat.com - Q3 EPS Estimates for Spyglass Pharma Decreased by Analyst
Q3 EPS Estimates for Spyglass Pharma Decreased by Analyst
MarketBeat

Spyglass Pharma, Inc. (NASDAQ:SGP - Free Report) - Equities research analysts at HC Wainwright cut their Q3 2026 earnings estimates for shares of Spyglass Pharma in a research report issued to clients and investors on Friday, August 7th. HC…

marketbeat.com - Innate Pharma (NASDAQ:IPHA) Stock Rating Upgraded by Leerink Partners
Innate Pharma (NASDAQ:IPHA) Stock Rating Upgraded by Leerink Partners
MarketBeat

Innate Pharma (NASDAQ:IPHA - Get Free Report) was upgraded by analysts at Leerink Partners from a 'market perform' rating to an 'outperform' rating in a report issued on Tuesday, Marketbeat Ratings reports. The brokerage presently has a $4.00 price…

marketbeat.com - Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Given Average Rating of 'Moderate Buy' by Analysts
Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA) Given Average Rating of 'Moderate Buy' by Analysts
MarketBeat

Shares of Innate Pharma S.A. Sponsored ADR (NASDAQ:IPHA - Get Free Report) have earned a consensus rating of 'Moderate Buy' from the six research firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has…

marketbeat.com - Morgan Stanley Has Lowered Expectations for BridgeBio Pharma (NASDAQ:BBIO) Stock Price
Morgan Stanley Has Lowered Expectations for BridgeBio Pharma (NASDAQ:BBIO) Stock Price
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price dropped by investment analysts at Morgan Stanley from $98.00 to $97.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage currently has an 'overweight'…

marketbeat.com - Piper Sandler Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
Piper Sandler Forecasts Strong Price Appreciation for BridgeBio Pharma (NASDAQ:BBIO) Stock
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price hoisted by investment analysts at Piper Sandler from $111.00 to $115.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an 'overweight' rating…

marketbeat.com - BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, TD Cowen Analyst Says
BridgeBio Pharma (NASDAQ:BBIO) Stock Price Expected to Rise, TD Cowen Analyst Says
MarketBeat

BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its price objective hoisted by investment analysts at TD Cowen from $95.00 to $110.00 in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a 'buy' rating on…

Receive a Daily briefing on Pharma Industry News

Get Started